'Gennova Biopharmaceuticals' - 6 News Result(s)
- India News | Reuters | Monday January 17, 2022India's Gennova Biopharmaceuticals is working on an Omicron-specific COVID-19 vaccine candidate that could be ready in a month or two, a person with direct knowledge of the matter told Reuters.
www.ndtv.com
- India News | Reuters | Tuesday August 24, 2021Pharmaceutical firm Gennova Biopharmaceuticals' COVID-19 vaccine, the first homegrown mRNA-based shot, was found to be safe and effective in an early-stage study, the government said on Tuesday.
www.ndtv.com
- India News | Press Trust of India | Tuesday April 13, 2021Pune-based Gennova Biopharmaceuticals has initiated the enrolment of volunteers for Phase 1/2 clinical trials for its mRNA vaccine candidate HGCO19, said the Department of Biotechnology, which provided seed funding for its development, on Tuesday.
www.ndtv.com
- India News | Reported by Sukirti Dwivedi, Edited by Vaibhav Tiwari | Friday December 11, 2020An anti-Coronavirus vaccine being developed by the Pune-based company, Gennova, has become the first indigenous mRNA candidate to have received approval to initiate human clinical trial, a central government statement has said.
www.ndtv.com
- India News | Press Trust of India | Thursday December 10, 2020The Drugs Controller General of India (DCGI) on Wednesday granted conditional permission for phases 1 and 2 human clinical trial of the COVID-19 vaccine candidate developed by the Pune-based Gennova Biopharmaceuticals Ltd in collaboration with HDT, USA, officials said.
www.ndtv.com
- India News | Press Trust of India | Tuesday November 24, 2020Ambassadors and envoys from 100 countries will visit Serum Institute of India and Gennova Biopharmaceuticals Ltd in Pune on December 4 amid the coronavirus outbreak and race for vaccines to combat the infection, a senior official said on Tuesday.
www.ndtv.com
'Gennova Biopharmaceuticals' - 2 Video Result(s)
'Gennova Biopharmaceuticals' - 6 News Result(s)
- India News | Reuters | Monday January 17, 2022India's Gennova Biopharmaceuticals is working on an Omicron-specific COVID-19 vaccine candidate that could be ready in a month or two, a person with direct knowledge of the matter told Reuters.
www.ndtv.com
- India News | Reuters | Tuesday August 24, 2021Pharmaceutical firm Gennova Biopharmaceuticals' COVID-19 vaccine, the first homegrown mRNA-based shot, was found to be safe and effective in an early-stage study, the government said on Tuesday.
www.ndtv.com
- India News | Press Trust of India | Tuesday April 13, 2021Pune-based Gennova Biopharmaceuticals has initiated the enrolment of volunteers for Phase 1/2 clinical trials for its mRNA vaccine candidate HGCO19, said the Department of Biotechnology, which provided seed funding for its development, on Tuesday.
www.ndtv.com
- India News | Reported by Sukirti Dwivedi, Edited by Vaibhav Tiwari | Friday December 11, 2020An anti-Coronavirus vaccine being developed by the Pune-based company, Gennova, has become the first indigenous mRNA candidate to have received approval to initiate human clinical trial, a central government statement has said.
www.ndtv.com
- India News | Press Trust of India | Thursday December 10, 2020The Drugs Controller General of India (DCGI) on Wednesday granted conditional permission for phases 1 and 2 human clinical trial of the COVID-19 vaccine candidate developed by the Pune-based Gennova Biopharmaceuticals Ltd in collaboration with HDT, USA, officials said.
www.ndtv.com
- India News | Press Trust of India | Tuesday November 24, 2020Ambassadors and envoys from 100 countries will visit Serum Institute of India and Gennova Biopharmaceuticals Ltd in Pune on December 4 amid the coronavirus outbreak and race for vaccines to combat the infection, a senior official said on Tuesday.
www.ndtv.com